Life Line Screening is a cutting-edge screening provider in the U.S. and abroad, and we are proud to have them implement our system around the world.
Indianapolis, IN (PRWEB) September 06, 2012
Polymer Technology Systems, Inc. (PTS), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, has announced the signing of a multiyear agreement to supply the CardioChek PA test system to Life Line Screening, a leading global provider of community-based preventive health screenings.
The CardioChek System provides on-site screening tests for the lipid panel that includes total cholesterol, triglycerides, LDL, and HDL, as well as glucose, and delivers the results in less than two minutes.
According to Life Line Screening’s Laboratory Medical Director, Benjamin Gerson, MD, “PTS is an ideal partner for us. Life Line Screening is certified under the CLIA federal mandate with a Certificate of Compliance, and as such, our focus is on quality. We have 60 community-based teams throughout the U.S., conducting approximately 15,000 health-screening events a year. The CardioChek system does not require a venous draw, allowing us to deliver fast results so our teams can provide clients with immediate feedback.”
Robert Huffstodt, President and CEO of PTS, Inc., is equally excited about the partnership. “Life Line Screening is a cutting-edge screening provider in the U.S. and abroad, and we are proud to have them implement our system around the world. They understand the role of preventive screening and have created a model that can deliver services on a global scale. This is very impressive and makes them a unique partner.” The ability to use this system globally is an important component of this partnership. “CardioChek is in over 120 countries, by far the most in the business,” said Kevin Luckow, Global Manager with Life Line Screening. “We are expanding our operations around the world, and they have the knowledge and experience in the intricacies of global business we need to grow.”
Life Line Screening intends to deploy the CardioChek Test System immediately. “PTS has the products, operational efficiencies, training, and distribution in place that we were looking for,” continued Luckow. “Their system is accurate and easy to use. It doesn’t require refrigeration and is battery operated, which are important operational benefits for our teams. We look forward to a long and mutually beneficial partnership.”
The CardioChek test system FDA-cleared for marketing in the U.S., in accordance with pre-market notification requirements set forth by the FDA, are CE-marked for marketing in the European Union and are licensed or registered as required for marketing globally.
About Life Line Screening
Life Line Screening was established in 1993, and has since become the nation’s leading provider of preventive health screenings. Highly trained clinical teams are on staff across the nation to bring affordable screenings to convenient, neighborhood locations. These non-invasive, painless tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough that they and their physicians can begin preventive procedures. Visit the web site at http://www.lifelinescreening.com or call 1-800-697-9177.
About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East and the Pacific Rim. PTS, Inc. products include the CardioChek® PA point-of-care instrument and the CardioChek® cholesterol analyzer that are marketed to the professional diagnostics industry and consumer screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek PA point-of-care instrument and the CardioChek Health Risk Assessment (HRA) software. For more information, visit http://www.cardiochek.com.
All trademarks used or mentioned in this release are protected by law.